Phase II dose-response pilot study of 3,4-methylenedioxymethamphetamine (MDMA)- assisted psychotherapy in subjects with anxiety associated with advanced-stage cancer.
Principal Investigator:	John H. Halpern, M.D. Biological Psychiatry Laboratory Alcohol and Drug Abuse Research Center McLean Hospital
Additional Investigators:	Todd D. Shuster, M.D. Department of Medical Oncology Lahey Clinic Medical Center
	Umadevi Naidoo, M.D. Department of Psychiatry Erich Lindemann Mental Health Center
	Arthur J. Siegel, M.D. Department of Internal Medicine McLean Hospital
Date:	November 19, 2004